An APRN is interested in trying to prevent mortality from acute stroke and decides to develop an online continuing education program to teach RNs, APRNs, and physician assistants about stroke protocols, including administration of tissue plasminogen activator (tPA), a thrombolytic therapy

An APRN is interested in trying to prevent mortality from acute stroke and decides to develop an online continuing education program to teach RNs, APRNs, and physician assistants about stroke protocols, including administration of tissue plasminogen activator (tPA), a thrombolytic therapy.

• What outcomes might the APRN monitor to determine the effectiveness of this program?

• The APRN takes a closer look at identifying subgroups in his or her community with the highest risk of stroke. In what ways can he or she tailor the educational intervention to better reach these groups at the community level? At the state level?